| Chugai Pharmaceutical (CHGCY) |
Japan |
$68.396B |
22.59 |
| Takeda Pharmaceutical (TAK) |
Japan |
$59.919B |
11.13 |
| UCB SA (UCBJY) |
Belgium |
$45.739B |
0.00 |
| Otsuka Holdings, - (OTSKY) |
Japan |
$39.680B |
14.84 |
| BeOne Medicines - (ONC) |
Switzerland |
$38.041B |
61.00 |
| Sandoz Group AG (SDZNY) |
Switzerland |
$35.464B |
0.00 |
| Daiichi Sankyo, - (DSNKY) |
Japan |
$34.072B |
21.27 |
| Zoetis (ZTS) |
United States |
$30.343B |
11.16 |
| Astellas Pharma (ALPMY) |
Japan |
$26.892B |
8.90 |
| United Therapeutics (UTHR) |
United States |
$21.460B |
17.90 |
| Merck (MKKGY) |
Germany |
$19.487B |
15.54 |
| Shionogi (SGIOY) |
Japan |
$15.947B |
9.37 |
| IPSEN (IPSEY) |
France |
$15.395B |
0.00 |
| Neurocrine Biosciences (NBIX) |
United States |
$15.249B |
20.72 |
| Summit Therapeutics (SMMT) |
United States |
$13.881B |
0.00 |
| Orion OYJ (ORINY) |
Finland |
$12.984B |
18.93 |
| Madrigal Pharmaceuticals (MDGL) |
United States |
$12.089B |
0.00 |
| Corcept Therapeutics (CORT) |
United States |
$11.979B |
263.86 |
| Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) |
Italy |
$11.965B |
15.26 |
| Crinetics Pharmaceuticals (CRNX) |
United States |
$9.013B |
0.00 |
| Eisai (ESAIY) |
|
$8.924B |
0.00 |
| Ionis Pharmaceuticals (IONS) |
United States |
$7.852B |
0.00 |
| Ono Pharmaceutical (OPHLF) |
Japan |
$7.049B |
13.27 |
| Stevanato Group S.p.A (STVN) |
Italy |
$6.523B |
32.64 |
| Centessa Pharmaceuticals (CNTA) |
United Kingdom |
$6.267B |
0.00 |
| Oruka Therapeutics (ORKA) |
United States |
$6.105B |
0.00 |
| AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$5.317B |
19.36 |
| Grifols, S.A (GRFS) |
Spain |
$5.009B |
0.00 |
| Definium Therapeutics (DFTX) |
United States |
$4.947B |
0.00 |
| Hikma Pharmaceuticals Plc (HKMPF) |
United Kingdom |
$4.923B |
0.00 |
| Relay Therapeutics (RLAY) |
United States |
$4.157B |
0.00 |
| Indivior Pharmaceuticals (INDV) |
United States |
$4.039B |
9.38 |
| Enliven Therapeutics (ELVN) |
United States |
$3.910B |
0.00 |
| Catalyst Pharmaceuticals (CPRX) |
United States |
$3.855B |
11.93 |
| Amylyx Pharmaceuticals (AMLX) |
United States |
$3.694B |
0.00 |
| Dyne Therapeutics (DYN) |
United States |
$3.343B |
0.00 |
| Hypermarcas (HYPMY) |
Brazil |
$3.203B |
9.10 |
| Soleno Therapeutics (SLNO) |
United States |
$2.717B |
228.83 |
| NewAmsterdam Pharma (NAMS) |
Netherlands |
$2.529B |
0.00 |
| Guardian Pharmacy Services (GRDN) |
United States |
$2.390B |
45.28 |
| Nektar Therapeutics (NKTR) |
United States |
$2.275B |
0.00 |
| Ocular Therapeutix (OCUL) |
United States |
$2.238B |
0.00 |
| Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$2.146B |
15.81 |
| Avadel Pharmaceuticals (AVDL) |
Ireland |
$2.113B |
0.00 |
| BioCryst Pharmaceuticals (BCRX) |
United States |
$2.085B |
5.63 |
| Xencor (XNCR) |
United States |
$1.766B |
0.00 |
| KARDIGAN INC (KARD) |
United States |
$1.735B |
0.00 |
| Xeris Biopharma Holdings (XERS) |
United States |
$1.366B |
107.00 |
| Harrow (HROW) |
United States |
$1.269B |
0.00 |
| Seaport Therapeutics (SPTX) |
United States |
$1.229B |
0.00 |
| Aktis Oncology (AKTS) |
United States |
$1.204B |
0.00 |
| Cronos Group (CRON) |
Canada |
$1.179B |
29.09 |
| Bioventus (BVS) |
United States |
$1.093B |
17.10 |
| Savara (SVRA) |
United States |
$1.081B |
0.00 |
| KalVista Pharmaceuticals (KALV) |
United States |
$0.993B |
0.00 |
| Cybin (HELP) |
Canada |
$0.992B |
0.00 |
| Theravance Biopharma (TBPH) |
United States |
$0.885B |
0.00 |
| Avalo Therapeutics (AVTX) |
United States |
$0.862B |
0.00 |
| Ardelyx (ARDX) |
United States |
$0.847B |
0.00 |
| Rigel Pharmaceuticals (RIGL) |
United States |
$0.821B |
11.32 |
| Esperion Therapeutics (ESPR) |
United States |
$0.819B |
0.00 |
| Aclaris Therapeutics (ACRS) |
United States |
$0.773B |
0.00 |
| Achieve Life Sciences (ACHV) |
Canada |
$0.753B |
0.00 |
| 4D Molecular Therapeutics (FDMT) |
United States |
$0.753B |
0.00 |
| Silence Therapeutics (SLN) |
United Kingdom |
$0.750B |
0.00 |
| Apnimed (APMD) |
|
$0.711B |
0.00 |
| Collegium Pharmaceutical (COLL) |
United States |
$0.711B |
3.13 |
| Zevra Therapeutics (ZVRA) |
United States |
$0.692B |
7.37 |
| Ironwood Pharmaceuticals (IRWD) |
United States |
$0.671B |
5.21 |
| OmniAb (OABI) |
United States |
$0.630B |
0.00 |
| Altimmune (ALT) |
United States |
$0.628B |
0.00 |
| Aquestive Therapeutics (AQST) |
United States |
$0.604B |
0.00 |
| Evotec AG (EVO) |
Germany |
$0.580B |
0.00 |
| ProKidney (PROK) |
United States |
$0.526B |
0.00 |
| Indaptus Therapeutics (INDP) |
United States |
$0.485B |
0.00 |
| Relmada Therapeutics (RLMD) |
United States |
$0.474B |
0.00 |
| ARS Pharmaceuticals (SPRY) |
United States |
$0.423B |
0.00 |
| Larimar Therapeutics (LRMR) |
United States |
$0.406B |
0.00 |
| Prelude Therapeutics (PRLD) |
United States |
$0.361B |
0.00 |
| Century Therapeutics (IPSC) |
United States |
$0.359B |
0.00 |
| Lexeo Therapeutics (LXEO) |
United States |
$0.339B |
0.00 |
| Inhibikase Therapeutics (IKT) |
United States |
$0.322B |
0.00 |
| Avita Medical (RCEL) |
United States |
$0.314B |
0.00 |
| Pyxis Oncology (PYXS) |
United States |
$0.278B |
0.00 |
| USANA Health Sciences (USNA) |
United States |
$0.275B |
15.05 |
| Elite Pharmaceuticals (ELTP) |
United States |
$0.268B |
12.44 |
| Lyell Immunopharma (LYEL) |
United States |
$0.267B |
0.00 |
| Akebia Therapeutics (AKBA) |
United States |
$0.250B |
0.00 |
| Galectin Therapeutics (GALT) |
United States |
$0.246B |
0.00 |
| Nature's Sunshine Products (NATR) |
United States |
$0.230B |
11.17 |
| AleAnna (ANNA) |
United States |
$0.226B |
17.84 |
| Protara Therapeutics (TARA) |
United States |
$0.222B |
0.00 |
| Cardiol Therapeutics (CRDL) |
Canada |
$0.215B |
0.00 |
| Siga Technologies (SIGA) |
United States |
$0.214B |
0.00 |
| Journey Medical (DERM) |
United States |
$0.208B |
0.00 |
| Profound Medical (PROF) |
Canada |
$0.208B |
0.00 |
| Korro Bio (KRRO) |
United States |
$0.207B |
0.00 |
| Surrozen (SRZN) |
United States |
$0.206B |
0.00 |
| Tonix Pharmaceuticals Holding (TNXP) |
United States |
$0.199B |
0.00 |
| Organogenesis (ORGO) |
United States |
$0.188B |
0.00 |
| Minerva Neurosciences (NERV) |
United States |
$0.183B |
0.00 |
| MediWound (MDWD) |
Israel |
$0.173B |
0.00 |
| Atrium Therapeutics (RNA) |
United States |
$0.173B |
0.00 |
| NRx Pharmaceuticals (NRXP) |
United States |
$0.147B |
0.00 |
| Innate Pharma SA (IPHYF) |
France |
$0.138B |
0.00 |
| Unicycive Therapeutics (UNCY) |
United States |
$0.131B |
0.00 |
| Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.129B |
0.00 |
| Assertio Holdings (ASRT) |
United States |
$0.116B |
0.00 |
| Rafael Holdings (RFL) |
United States |
$0.111B |
0.00 |
| Vivani Medical (VANI) |
United States |
$0.111B |
0.00 |
| Allergy Therapeutics (AGYTF) |
United Kingdom |
$0.103B |
0.00 |
| Cassava Sciences (SAVA) |
United States |
$0.101B |
0.00 |
| Cumberland Pharmaceuticals (CPIX) |
United States |
$0.099B |
0.00 |
| PolyPid (PYPD) |
Israel |
$0.098B |
0.00 |
| HST Global (HSTC) |
United States |
$0.092B |
0.00 |
| ElectroCore (ECOR) |
United States |
$0.091B |
0.00 |
| Fractyl Health (GUTS) |
United States |
$0.090B |
0.00 |
| Nutriband (NTRB) |
United States |
$0.083B |
0.00 |
| Aldeyra Therapeutics (ALDX) |
United States |
$0.083B |
0.00 |
| Telomir Pharmaceuticals (TELO) |
United States |
$0.080B |
0.00 |
| Verrica Pharmaceuticals (VRCA) |
United States |
$0.079B |
0.00 |
| Acrivon Therapeutics (ACRV) |
United States |
$0.078B |
0.00 |
| Gain Therapeutics (GANX) |
United States |
$0.075B |
0.00 |
| PMV Pharmaceuticals (PMVP) |
United States |
$0.073B |
0.00 |
| Champions Oncology (CSBR) |
United States |
$0.066B |
0.00 |
| Talphera (TLPH) |
United States |
$0.062B |
0.00 |
| Nuo Therapeutics (AURX) |
|
$0.061B |
0.00 |
| Heron Therapeutics (HRTX) |
United States |
$0.060B |
0.00 |
| Dominari Holdings (DOMH) |
United States |
$0.053B |
0.00 |
| Veraxa Biotech AG (VRXA) |
United States |
$0.048B |
0.00 |
| SCYNEXIS (SCYX) |
United States |
$0.044B |
0.00 |
| Incannex Healthcare (IXHL) |
Australia |
$0.041B |
0.00 |
| FibroGen (FGEN) |
United States |
$0.039B |
0.00 |
| Lite Strategy (LITS) |
United States |
$0.037B |
0.00 |
| Mural Oncology (MURA) |
Ireland |
$0.035B |
0.00 |
| Karyopharm Therapeutics (KPTI) |
United States |
$0.035B |
0.00 |
| Context Therapeutics (CNTX) |
United States |
$0.033B |
0.00 |
| Optimi Health (OPTH) |
Canada |
$0.029B |
0.00 |
| Cosmos Health (COSM) |
United States |
$0.028B |
0.00 |
| TransCode Therapeutics (RNAZ) |
United States |
$0.027B |
0.00 |
| Plus Therapeutics (PSTV) |
United States |
$0.027B |
0.00 |
| TherapeuticsMD (TXMD) |
United States |
$0.025B |
0.00 |
| Universe Pharmaceuticals INC (UPC) |
China |
$0.022B |
0.00 |
| MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.020B |
0.00 |
| VYNE Therapeutics (VYNE) |
United States |
$0.019B |
0.00 |
| Lipocine (LPCN) |
United States |
$0.018B |
0.00 |
| Klotho Neurosciences (KLTO) |
United States |
$0.016B |
0.00 |
| Mannatech (MTEX) |
United States |
$0.016B |
0.00 |
| Enlivex (ENLV) |
Israel |
$0.015B |
0.00 |
| Citius Pharmaceuticals (CTXR) |
United States |
$0.015B |
0.00 |
| BioVie (BIVI) |
United States |
$0.015B |
0.00 |
| Iterum Therapeutics (ITRM) |
Ireland |
$0.015B |
0.00 |
| Vyome Holdings (HIND) |
United States |
$0.014B |
0.00 |
| Quoin Pharmaceuticals (QNRX) |
United States |
$0.014B |
0.00 |
| Scienture Holdings (SCNX) |
United States |
$0.014B |
0.00 |
| Tempest Therapeutics (TPST) |
United States |
$0.012B |
0.00 |
| Natural Alternatives (NAII) |
United States |
$0.012B |
0.00 |
| BioLineRx (BLRX) |
Israel |
$0.012B |
0.00 |
| Phio Pharmaceuticals (PHIO) |
United States |
$0.012B |
0.00 |
| Kiora Pharmaceuticals (KPRX) |
United States |
$0.012B |
0.00 |
| CASI Pharmaceuticals (CASI) |
China |
$0.010B |
0.00 |
| Xenetic Biosciences (XBIO) |
United States |
$0.010B |
0.00 |
| Mangoceuticals (MGRX) |
United States |
$0.009B |
0.00 |
| Wellgistics Health (WGRX) |
United States |
$0.009B |
0.00 |
| Traws Pharma (TRAW) |
United States |
$0.008B |
0.00 |
| Inotiv (NOTV) |
United States |
$0.008B |
0.00 |
| Biomerica (BMRA) |
United States |
$0.007B |
0.00 |
| Curanex Pharmaceuticals Inc (CURX) |
United States |
$0.007B |
0.00 |
| Ernexa Therapeutics (ERNA) |
United States |
$0.007B |
0.00 |
| Sonoma Pharmaceuticals (SNOA) |
United States |
$0.006B |
0.00 |
| XTL Biopharmaceuticals (XTLB) |
Israel |
$0.006B |
0.00 |
| Heatwurx (PCSA) |
United States |
$0.005B |
0.00 |
| Salarius Pharmaceuticals (SLRX) |
United States |
$0.005B |
0.00 |
| Galmed Pharmaceuticals (GLMD) |
Israel |
$0.005B |
0.00 |
| Liminatus Pharma (LIMN) |
United States |
$0.005B |
0.00 |
| Aptorum Group (APM) |
United Kingdom |
$0.004B |
0.00 |
| InMed Pharmaceuticals (INM) |
Canada |
$0.004B |
0.00 |
| Niki BioSolutions (NIKI) |
United Kingdom |
$0.004B |
0.00 |
| Nuvilex (PMCB) |
United States |
$0.004B |
0.00 |
| Addex Therapeutics (ADXN) |
Switzerland |
$0.004B |
0.00 |
| Galmed Pharmaceuticals (EOCN) |
Israel |
$0.004B |
0.00 |
| Alaunos Therapeutics (TCRT) |
United States |
$0.004B |
0.00 |
| Redhill Biopharma (RDHL) |
Israel |
$0.004B |
0.00 |
| XORTX Therapeutics (XRTX) |
Canada |
$0.003B |
0.00 |
| 60 Degrees Pharmaceuticals (SXTP) |
United States |
$0.003B |
0.00 |
| Jupiter Neurosciences (JUNS) |
United States |
$0.003B |
0.00 |
| SciSparc (SPRC) |
Israel |
$0.003B |
0.00 |
| Vivos Therapeutics (VVOS) |
United States |
$0.002B |
0.00 |
| Shuttle Pharmaceuticals Holdings (SHPH) |
United States |
$0.002B |
0.00 |
| Jaguar Animal Health (JAGX) |
United States |
$0.001B |
0.00 |
| China SXT Pharmaceuticals (SXTC) |
China |
$0.001B |
0.00 |
| Clearmind Medicine (CMND) |
Canada |
$0.001B |
0.00 |
| PainReform (PRFX) |
Israel |
$0.001B |
0.00 |
| CDT Equity (CDT) |
United States |
$0.000B |
0.00 |
| Emisphere Technologies (EMIS) |
United States |
$0.000B |
0.00 |
| 4D Pharma (LBPS) |
United Kingdom |
$0.000B |
0.00 |
| Patheon (PTHN) |
Netherlands |
$0.000B |
0.00 |
| RVL Pharmaceuticals (RVLP) |
United States |
$0.000B |
0.00 |
